Sign inJoin waitlistJoin the waitlist

CK

Christopher Kurtz

Cardiovascular Disease

Credentials: · ·

History

Cardiovascular Disease
Internal Medicine

Research

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
New England Journal of Medicine · 2021 · 487 citations
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
Circulation · 2018 · 203 citations
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF
Review · JACC Heart Failure · 2020 · 116 citations

NH
Narimon Honarpour
7 papers
MS
Marc Sabatine
5 papers
RG
Robert Giugliano
5 papers
FM
Fady Malik
4 papers
Gary Felker
4 papers
John Teerlink
4 papers
SS
Scott Solomon
4 papers
SA
Siddique Abbasi
3 papers
SW
Stephen Wiviott
3 papers
Darko Pucar
2 papers · 1 as a resident
David Lanfear
2 papers
IA
Inderjit Anand
2 papers